Trial Profile
The Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Metastatic Breast Cancer Patients Previously Responsive to Hormonal Therapy: A Phase II Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Anastrozole; Exemestane; Letrozole; Tamoxifen
- Indications Advanced breast cancer; Carcinoma
- Focus Therapeutic Use
- 26 Sep 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 26 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Dec 2010 Planned end date changed from 1 Dec 2010 to 1 May 2011 as reported by ClinicalTrials.gov.